Back to top

Image: Bigstock

Why Evolent Health (EVH) Isn't Done Growing Earnings Yet

Read MoreHide Full Article

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is Evolent Health, Inc. (EVH - Free Report) . This firm, which is in the Internet - Software industry, saw a EPS growth of 33.3% last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 77%. Furthermore, the long-term growth rate is currently an impressive 30%, suggesting pretty good prospects for the long haul.

Evolent Health, Inc Price and Consensus

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 10%. Thanks to this rise in earnings estimates, EVH has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider EVH. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for EVH as well.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Evolent Health, Inc (EVH) - free report >>

Published in